Navigation Links
Graphene: What can go wrong? new studies point to wrinkles, process contaminants
Date:7/7/2011

Using a combination of sophisticated computer modeling and advanced materials analysis techniques at synchrotron laboratories, a research team led by the University at Buffalo (UB) and including the National Institute of Standards and Technology (NIST), the Molecular Foundry at Lawrence Berkeley National Laboratory and SEMATECH* has demonstrated how some relatively simple processing flaws can seriously degrade the otherwise near-magical electronic properties of graphene.

Their new paper** demonstrates how both wrinkles in the graphene sheet and/or chance contaminants from processingpossibly hiding in those foldsdisrupt and slow electron flow across the sheet. The results could be important for the design of commercial manufacturing processes that exploit the unique electrical properties of graphene. In the case of contaminant molecules at least, the paper also suggests that heating the graphene may be a simple solution.

Graphene, a nanostructured material that is essentially a one-atom thick sheet of carbon atoms arranged in a hexagonal pattern, is under intense study because of a combination of outstanding properties. It's extremely strong, conducts heat very well, and has high electrical conductivity while being flexible and transparent. Graphene's electrical properties, however, apparently depend a lot on flatness and purity.

Using X-rays, the UB team produced images that show the electron "cloud" lining the surface of graphene samplesthe structure responsible for the high-speed transit of electrons across the sheetand how wrinkles in the sheet distort the cloud and create bottlenecks. Spectrographic data showed anomalous "peaks" in some regions that also corresponded to distortions of the cloud. NIST researchers, using their dedicated materials science "beam line" at the National Synchrotron Light Source (NSLS),*** contributed a sensitive analysis of spectroscopic data confirming that these peaks were caused by chemical contaminants that adhered to the graphene during processing.

Significantly, the NIST synchrotron methods group was able to make detailed spectroscopic measurements of the graphene samples while heating them, and found that the mysterious peaks disappeared by the time the sample reached 150 degrees Celsius. This, according to Dan Fischer, leader of the NIST group, showed both that those particular disturbances in the electron cloud were due to contaminants, and that there is a way to get rid of them. "They're not chemical bound, they're just physically absorbed on the surface, and that's an important thing. You have a prescription for getting rid of them," Fischer said.

"When graphene was discovered, people were just so excited that it was such a good material that people really wanted to go with it and run as fast as possible," said Brian Schultz, one of three UB graduate students who were lead authors on the paper, "but what we're showing is that you really have to do some fundamental research before you understand how to process it and how to get it into electronics."

"This is the practical side of using graphene," agrees Fischer, "It has all these remarkable properties, but when you go to actually try to make something, maybe they stop working, and the question is: why and what do you do about it? These kinds of extremely sensitive, specialized techniques are part of that answer."


'/>"/>

Contact: Michael Baum
baum@nist.gov
301-975-2763
National Institute of Standards and Technology (NIST)
Source:Eurekalert

Related biology technology :

1. Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research
2. Genomic Health Presents Multiple International Studies Demonstrating Worldwide Value of Oncotype DX® Breast Cancer Test
3. Otonomys OTO-104 Demonstrates Hearing Loss Protection and Hearing Recovery in Preclinical Studies
4. Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium
5. Precision Therapeutics Announces Two Pancreatic Cancer Studies Emphasizing the Utility of ChemoFx® in Cancer Treatment Options
6. Halt Medical Presents Strong Results of International Fibroid Studies at National Institutes of Health Global Congress
7. Ocera Therapeutics Completes First in Human Studies with OCR-002 for the Treatment of Hyperammonemia and Hepatic Encephalopathy
8. Alder Biopharmaceuticals Announces That Data From Multiple Studies of ALD518 (BMS945429), an Investigational Antibody Therapeutic in Rheumatoid Arthritis Patients, to be Presented at Annual Meeting of the American College of Rheumatology
9. Omeros Announces Additional Support from the National Institute on Drug Abuse for Clinical Studies in Addiction Program
10. Helix BioPharma Completes Definitive GLP Toxicology Studies With L-DOS47 and is Making Final Preparations for its Planned Phase I/II Clinical Study IND/CTA Submissions
11. Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Malden, MA (PRWEB) , ... February 24, 2017 ... ... disc replacement (TDR) procedures can be safely completed in an ambulatory surgery center ... and fusion (ACDF) procedures and previous two-year TDR studies. , Jake Lubinski, ...
(Date:2/24/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today is ... in its previously announced rights offering of up ... common stock and Series C Convertible Preferred Stock ... As previously announced, the rights ...
(Date:2/24/2017)...  Driven by consumers, preference towards more natural ... growing categories, finds the recently published U.S. volume ... Multi-regional Market Analysis and Opportunities study by ... "Biotechnology actives are derived from natural ... for skin and hair care applications," explains ...
(Date:2/24/2017)... Feb. 23, 2017 China Biologic Products, Inc. (NASDAQ: ... plasma-based biopharmaceutical company in China, today announced its financial results ... Fourth Quarter 2016 Financial Highlights ... by 21.7% in RMB terms, or increased by 13.6% in ... same quarter of 2015. Gross profit increased ...
Breaking Biology Technology:
(Date:2/16/2017)... Feb. 16, 2017  Genos, a community for ... it has received Laboratory Accreditation from the College ... presented to laboratories that meet stringent requirements around ... rigorous processes. "Genos is committed to ... practices. We,re honored to be receiving CAP accreditation," ...
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 ... growing at a compound annual growth rate (CAGR) of 24.0% ... global markets for synthetic biology. - Analyses of global market ... of compound annual growth rates (CAGRs) through 2021. - Coverage ...
Breaking Biology News(10 mins):